{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:07:02Z","timestamp":1790446022226,"version":"4.1.0"},"reference-count":253,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CONACyT","award":["51541"],"award-info":[{"award-number":["51541"]}]},{"name":"CONACyT","award":["83521"],"award-info":[{"award-number":["83521"]}]},{"name":"CONACyT","award":["47425"],"award-info":[{"award-number":["47425"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.cbi.2010.04.010","type":"journal-article","created":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T04:38:39Z","timestamp":1271479119000},"page":"184-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"title":["The transition metals copper and iron in neurodegenerative diseases"],"prefix":"10.1016","volume":"186","author":[{"given":"Susana","family":"Rivera-Manc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"P\u00e9rez-Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Trist\u00e1n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Rivera-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2010.04.010_bib1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/sj.bjp.0706416","article-title":"The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy","volume":"146","author":"Gaeta","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2010.04.010_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.physbeh.2005.08.010","article-title":"Trace metal regulation of neuronal apoptosis: from genes to behavior","volume":"86","author":"Levenson","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.cbi.2010.04.010_bib3","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1038\/399a003","article-title":"New order from neurological disorders","volume":"399","author":"Price","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2010.04.010_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0047-6374(00)00124-X","article-title":"Will antioxidants fulfill their expectations for the treatment of Alzheimer disease?","volume":"116","author":"Rottkamp","year":"2000","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.cbi.2010.04.010_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mad.2004.08.023","article-title":"Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases","volume":"126","author":"Youdim","year":"2005","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.cbi.2010.04.010_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.nutr.23.020102.075739","article-title":"Iron status and neural functioning","volume":"23","author":"Beard","year":"2003","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.cbi.2010.04.010_bib7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69002.x","article-title":"Cellular iron metabolism","volume":"69","author":"Ponka","year":"1999","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.cbi.2010.04.010_bib8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jn\/129.7.1251","article-title":"A delicate balance: homeostatic control of copper uptake and distribution","volume":"129","author":"Pe\u00f1a","year":"1999","journal-title":"J. Nutr."},{"issue":"Suppl.","key":"10.1016\/j.cbi.2010.04.010_bib9","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/ana.410320710","article-title":"Iron regulation in the brain: histochemical, biochemical, and molecular considerations","volume":"32","author":"Connor","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0887-8994(01)00260-0","article-title":"Systemic iron metabolism: a review and implications for brain iron metabolism","volume":"25","author":"Rouault","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.rmr.0000245461.90406.ad","article-title":"Role of iron in neurodegenerative disorders","volume":"17","author":"Berg","year":"2006","journal-title":"Top. Magn. Reson. Imag."},{"issue":"Suppl.","key":"10.1016\/j.cbi.2010.04.010_bib12","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/ana.410320716","article-title":"Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group","volume":"32","author":"Dexter","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.cbi.2010.04.010_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/146642409111100506","article-title":"Oxygen free radicals and human diseases","volume":"111","author":"Aruoma","year":"1991","journal-title":"J. R. Soc. Health"},{"key":"10.1016\/j.cbi.2010.04.010_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/14660820310011278","article-title":"Relevance of oxidative injury in the pathogenesis of motor neuron diseases","volume":"4","author":"Agar","year":"2003","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"10.1016\/j.cbi.2010.04.010_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.neuro.30.051606.094232","article-title":"Copper and iron disorders of the brain","volume":"30","author":"Madsen","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/41343","article-title":"Cloning and characterization of a mammalian protein-coupled metal\u2013ion transporter","volume":"388","author":"Gunshin","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2010.04.010_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ncl.2007.03.008","article-title":"Alzheimer's disease and mild cognitive impairment","volume":"25","author":"Kelley","year":"2007","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.cbi.2010.04.010_bib19","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Alzheimer's Disease International, global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2010.04.010_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-7091-7508-8_8","article-title":"Neuropathology of Alzheimer's disease: a critical update","volume":"54","author":"Jellinger","year":"1998","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.cbi.2010.04.010_bib21","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","article-title":"Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels","volume":"4","author":"Masters","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2010.04.010_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ncl.2007.03.007","article-title":"An update on the amyloid hypothesis","volume":"25","author":"Eckman","year":"2007","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.cbi.2010.04.010_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2010.04.010_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.2949367","article-title":"Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus","volume":"235","author":"Tanzi","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.cbi.2010.04.010_bib25","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2010.04.010_bib26","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0006-291X(88)80486-8","article-title":"Different processing of Alzheimer's beta-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type","volume":"151","author":"Prelli","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2010.04.010_bib27","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1111\/j.1742-4658.2007.05918.x","article-title":"The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease","volume":"274","author":"Crouch","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2010.04.010_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsb.2005.12.011","article-title":"Metal exposure and Alzheimer's pathogenesis","volume":"155","author":"Liu","year":"2006","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.cbi.2010.04.010_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1096\/fj.04-1890fje","article-title":"Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid","volume":"18","author":"Barnham","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2010.04.010_bib31","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/bi990438f","article-title":"The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction","volume":"38","author":"Huang","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2010.04.010_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1006\/bbrc.1995.2678","article-title":"The role of iron in beta amyloid toxicity","volume":"216","author":"Schubert","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2010.04.010_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1096-8628(20000703)93:1<58::AID-AJMG10>3.0.CO;2-L","article-title":"Are hereditary hemochromatosis mutations involved in Alzheimer disease?","volume":"93","author":"Moalem","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.cbi.2010.04.010_bib34","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","article-title":"An iron-responsive element type II in the 5\u2032-untranslated region of the Alzheimer's amyloid precursor protein transcript","volume":"277","author":"Rogers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib35","first-page":"191","article-title":"Most amyloid plaques contain ferritin rich cells","volume":"1","author":"Robinson","year":"1995","journal-title":"Alz. Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/jmri.21730","article-title":"Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease","volume":"29","author":"Ding","year":"2009","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.cbi.2010.04.010_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer's disease","volume":"337","author":"Crapper McLachlan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2010.04.010_bib38","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1471-4159.2009.05901.x","article-title":"Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD","volume":"108","author":"Kitazawa","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib39","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","article-title":"Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1\u201342","volume":"75","author":"Atwood","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib40","doi-asserted-by":"crossref","first-page":"37111","DOI":"10.1074\/jbc.274.52.37111","article-title":"Cu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction","volume":"274","author":"Huang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib41","doi-asserted-by":"crossref","first-page":"40302","DOI":"10.1074\/jbc.M206428200","article-title":"Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2)","volume":"277","author":"Opazo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib42","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","article-title":"Brain cytochrome oxidase in Alzheimer's disease","volume":"59","author":"Kish","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1471-4159.2006.04050.x","article-title":"Copper-dependent inhibition of cytochrome c oxidase by Abeta(1\u201342) requires reduced methionine at residue 35 of the Abeta peptide","volume":"99","author":"Crouch","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1523\/JNEUROSCI.4276-04.2005","article-title":"Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1\u201342","volume":"25","author":"Crouch","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1523\/JNEUROSCI.3699-04.2005","article-title":"NMDA receptor activation mediates copper homeostasis in hippocampal neurons","volume":"25","author":"Schlief","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-8993(99)01861-2","article-title":"Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice","volume":"842","author":"White","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib47","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1212\/01.WNL.0000154531.79362.23","article-title":"Excess of serum copper not related to ceruloplasmin in Alzheimer disease","volume":"64","author":"Squitti","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.04.010_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1212\/01.wnl.0000223343.82809.cf","article-title":"Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau","volume":"67","author":"Squitti","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.04.010_bib49","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.M400805200","article-title":"Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene","volume":"279","author":"Bellingham","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2007.10.012","article-title":"Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid","volume":"30","author":"Strozyk","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2010.04.010_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/01902140303753","article-title":"Differential production of metalloproteinases after instilling various urban air particle samples to rat lung","volume":"29","author":"Adamson","year":"2003","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib52","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1165\/rcmb.2003-0233OC","article-title":"Heparin-binding epidermal growth factor cleavage mediates zinc-induced epidermal growth factor receptor phosphorylation","volume":"30","author":"Wu","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cbi.2010.04.010_bib53","doi-asserted-by":"crossref","first-page":"17670","DOI":"10.1074\/jbc.M602487200","article-title":"Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity","volume":"281","author":"White","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Pt. 2","key":"10.1016\/j.cbi.2010.04.010_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/bj3440461","article-title":"Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion","volume":"344","author":"Borchardt","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2010.04.010_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BJ20080103","article-title":"Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms","volume":"412","author":"Cater","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2010.04.010_bib56","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11064-008-9610-3","article-title":"Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases","volume":"33","author":"Boll","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients","volume":"21","author":"Maurer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2010.04.010_bib58","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1042\/BST0361277","article-title":"Ceruloplasmin in neurodegenerative diseases","volume":"36","author":"Texel","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cbi.2010.04.010_bib59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0006-8993(96)00782-2","article-title":"Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders","volume":"738","author":"Loeffler","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0304-3940(93)90805-U","article-title":"Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease","volume":"159","author":"Connor","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2010.04.010_bib61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-4159.2006.04258.x","article-title":"Therapeutic targets and potential of the novel brain-permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease","volume":"100","author":"Avramovich-Tirosh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib62","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1523\/JNEUROSCI.1521-05.2005","article-title":"Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice","volume":"25","author":"Rezai-Zadeh","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib63","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-4159.2006.03770.x","article-title":"Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (\u2212)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease","volume":"97","author":"Reznichenko","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib64","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cbi.2010.04.010_bib66","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1021\/jm070800l","article-title":"A Novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities","volume":"51","author":"Blat","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib67","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","article-title":"Selective iron chelation in Friedreich ataxia: biologic and clinical implications","volume":"110","author":"Boddaert","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2010.04.010_bib68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neulet.2006.07.020","article-title":"Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance","volume":"406","author":"Liu","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2010.04.010_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2009.03.064","article-title":"Nanoparticle\u2013chelator conjugates as inhibitors of amyloid-aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease","volume":"455","author":"Liu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2010.04.010_bib70","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1074\/jbc.274.33.23223","article-title":"Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion","volume":"274","author":"Cherny","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2362.2002.00933.x","article-title":"d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients","volume":"32","author":"Squitti","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cbi.2010.04.010_bib72","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1523\/JNEUROSCI.0059-07.2007","article-title":"Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP\/PS1 mice without affecting beta-amyloid burden","volume":"27","author":"Malm","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper\u2013zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2010.04.010_bib74","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00109-006-0140-7","article-title":"Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal\u2013ion levels","volume":"85","author":"Sch\u00e4fer","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.cbi.2010.04.010_bib76","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1074\/jbc.M705957200","article-title":"Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide","volume":"283","author":"Donnelly","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1073\/pnas.0809057106","article-title":"Increasing Cu bioavailability inhibits A oligomers and tau phosphorylation","volume":"106","author":"Crouch","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib78","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1021\/jm701225u","article-title":"Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease","volume":"50","author":"Bolognesi","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib79","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-2952(02)01174-7","article-title":"Glutathione, iron and Parkinson's disease","volume":"64","author":"Bharath","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2010.04.010_bib80","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.reprotox.2007.01.007","article-title":"The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder","volume":"23","author":"Barlow","year":"2007","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.cbi.2010.04.010_bib81","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.arr.2004.01.003","article-title":"Does cellular iron dysregulation play a causative role in Parkinson's disease?","volume":"3","author":"Kaur","year":"2004","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cbi.2010.04.010_bib82","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0891988704267466","article-title":"Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease","volume":"17","author":"Burn","year":"2004","journal-title":"J Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib83","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(07)60238-4","article-title":"Sexual function in men and women with neurological disorders","volume":"369","author":"Rees","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2010.04.010_bib84","first-page":"573","article-title":"Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase","volume":"54","author":"Graumann","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.cbi.2010.04.010_bib85","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1212\/01.WNL.0000166916.40902.63","article-title":"Searching for a relationship between manganese and welding and Parkinson's disease","volume":"64","author":"Jankovic","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.04.010_bib86","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jns.2003.09.014","article-title":"Multiple risk factors for Parkinson's disease","volume":"217","author":"Gorell","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib87","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1306.017","article-title":"The relevance of iron in the pathogenesis of Parkinson's disease","volume":"1012","author":"G\u00f6tz","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(02)03179-7","article-title":"Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats","volume":"952","author":"Castellanos","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib89","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuron.2006.07.011","article-title":"NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1","volume":"51","author":"Cheah","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2010.04.010_bib90","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.expneurol.2003.08.006","article-title":"The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration","volume":"184","author":"Double","year":"2003","journal-title":"Exp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.cbi.2010.04.010_bib91","doi-asserted-by":"crossref","first-page":"I24","DOI":"10.1007\/s00415-003-1104-0","article-title":"Does ultrasound disclose a vulnerability factor for Parkinson's disease?","volume":"250","author":"Behnke","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib92","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib93","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","article-title":"Individual dopaminergic neurons show raised iron levels in Parkinson disease","volume":"68","author":"Oakley","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.04.010_bib94","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains","volume":"52","author":"Riederer","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/1531-8257(200101)16:1<23::AID-MDS1003>3.0.CO;2-2","article-title":"Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound","volume":"16","author":"Becker","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cbi.2010.04.010_bib96","doi-asserted-by":"crossref","unstructured":"R. Mart\u00ednez-Hernandez, S. Montes, J. Higuera-Calleja, P. Yescas, M.C. Boll, C. Rios, Plasma ceruloplasmin ferroxidase activity correlates with nigral sonographic area. 2010, unpublished results.","DOI":"10.1007\/s11064-011-0535-x"},{"key":"10.1016\/j.cbi.2010.04.010_bib97","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archneur.59.6.999","article-title":"Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury","volume":"59","author":"Berg","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib98","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1148\/radiology.211.2.r99ma53489","article-title":"T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content","volume":"211","author":"Vymazal","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.cbi.2010.04.010_bib99","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archneurol.2008.586","article-title":"Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism","volume":"66","author":"Brar","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neurobiolaging.2005.12.010","article-title":"Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys","volume":"28","author":"Cass","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2010.04.010_bib101","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbabio.2004.03.016","article-title":"Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols","volume":"1658","author":"Brown","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2010.04.010_bib102","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1167\/iovs.07-1472","article-title":"Ceruloplasmin\/hephaestin knockout mice model morphologic and molecular features of AMD","volume":"49","author":"Hadziahmetovic","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib103","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1111\/j.1460-9568.2007.05515.x","article-title":"Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib104","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1212\/01.WNL.0000144276.29988.C3","article-title":"Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease","volume":"63","author":"Hochstrasser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.04.010_bib105","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease","volume":"105","author":"Salazar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib106","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","article-title":"Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2010.04.010_bib107","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-4159.2005.03532.x","article-title":"Melatonin and 6-hydroxymelatonin protect against iron-induced neurotoxicity","volume":"96","author":"Maharaj","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib108","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.lfs.2006.11.031","article-title":"Mechanisms by which acyclovir reduces the oxidative neurotoxicity and biosynthesis of quinolinic acid","volume":"80","author":"Muller","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib109","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0891-5849(01)00679-7","article-title":"Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants","volume":"31","author":"Mendez-Alvarez","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2010.04.010_bib110","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000","article-title":"The A53 T alpha-synuclein mutation increases iron-dependent aggregation and toxicity","volume":"20","author":"Ostrerova-Golts","year":"2000","journal-title":"J. Neurosci."},{"issue":"Suppl.","key":"10.1016\/j.cbi.2010.04.010_bib111","first-page":"S3","article-title":"What causes cell death in Parkinson's disease?","volume":"64","author":"Gupta","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib112","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neurobiolaging.2006.04.003","article-title":"Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age","volume":"28","author":"Kaur","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2010.04.010_bib113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-4328(02)00035-9","article-title":"Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration","volume":"139","author":"Fredriksson","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib114","doi-asserted-by":"crossref","first-page":"C2197","DOI":"10.1152\/ajpcell.00620.2006","article-title":"Upregulation of -glutamate-cysteine ligase as part of the long-term adaptation process to iron accumulation in neuronal","volume":"292","author":"Aguirre","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.cbi.2010.04.010_bib115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.mam.2005.07.010","article-title":"Iron and copper metabolism","volume":"26","author":"Arredondo","year":"2005","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.cbi.2010.04.010_bib116","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1088\/0031-9155\/54\/3\/012","article-title":"Mapping metals in Parkinson's and normal brain using rapid-scanning X-ray fluorescence","volume":"54","author":"Popescu","year":"2009","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.cbi.2010.04.010_bib117","doi-asserted-by":"crossref","first-page":"1017S","DOI":"10.1093\/ajcn\/67.5.1017S","article-title":"Clinical conditions altering copper metabolism in humans","volume":"67","author":"Beshgetoor","year":"1998","journal-title":"Am. J Clin. Nutr."},{"key":"10.1016\/j.cbi.2010.04.010_bib118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(99)00221-9","article-title":"Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease","volume":"265","author":"Boll","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2010.04.010_bib119","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1073\/pnas.0407881102","article-title":"Structural characterization of copper(II) binding to alpha-synuclein: insights into the bioinorganic chemistry of Parkinson's disease","volume":"102","author":"Rasia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib120","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib121","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1471-4159.2003.01612.x","article-title":"Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2","volume":"84","author":"Lee","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib122","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/abbi.2000.1822","article-title":"Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide","volume":"378","author":"Paik","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2010.04.010_bib123","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0300-9084(02)01435-9","article-title":"The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro","volume":"84","author":"Kim","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.cbi.2010.04.010_bib124","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1110\/ps.04879704","article-title":"Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain","volume":"13","author":"Lowe","year":"2004","journal-title":"Protein Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib125","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1523\/JNEUROSCI.21-10-03322.2001","article-title":"Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity","volume":"21","author":"Wang","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jn\/122.1.65","article-title":"Low copper status of rats affects polyunsaturated fatty acid composition of brain phospholipids, unrelated to neuropathology","volume":"122","author":"Sun","year":"1992","journal-title":"J. Nutr."},{"key":"10.1016\/j.cbi.2010.04.010_bib127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1007680616056","article-title":"Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice","volume":"26","author":"Alcaraz-Zubeldia","year":"2001","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuint.2009.01.019","article-title":"Copper reduces striatal protein nitration and tyrosine hydroxylase inactivation induced by MPP+ in rats","volume":"54","author":"Rubio-Osornio","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cbi.2010.04.010_bib129","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0891-5849(03)00317-4","article-title":"Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems","volume":"35","author":"Santamaria","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2010.04.010_bib130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00702-006-0499-1","article-title":"The copper chelator, d-penicillamine, does not attenuate MPTP induced dopamine depletion in mice","volume":"114","author":"Youdim","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.cbi.2010.04.010_bib131","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-0773.1995.tb00160.x","article-title":"Depletion of copper and manganese in brain after MPTP treatment of mice","volume":"76","author":"Rios","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2010.04.010_bib132","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2202-6-3","article-title":"Iron homeostasis in neuronal cells: a role for IREG1","volume":"6","author":"Aguirre","year":"2005","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib133","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.gastro.2008.04.007","article-title":"Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease","volume":"135","author":"Aigner","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2010.04.010_bib134","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bcmd.2005.11.003","article-title":"Mild copper deficiency alters gene expression of proteins involved in iron metabolism","volume":"36","author":"Auclair","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cbi.2010.04.010_bib135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20060963","article-title":"Regulation of ceruloplasmin in human hepatic cells by redox active copper: identification of a novel AP-1 site in the ceruloplasmin gene","volume":"402","author":"Das","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2010.04.010_bib136","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/sj.emboj.7601735","article-title":"Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin","volume":"26","author":"De Domenico","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2010.04.010_bib137","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2010.04.010_bib138","doi-asserted-by":"crossref","first-page":"19099","DOI":"10.1074\/jbc.M400101200","article-title":"1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide","volume":"279","author":"Shang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib139","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/ije\/28.6.1102","article-title":"Adult nutrient intake as a risk factor for Parkinson's disease","volume":"28","author":"Johnson","year":"1999","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.cbi.2010.04.010_bib140","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2004.08.014","article-title":"Role of dietary iron restriction in a mouse model of Parkinson's disease","volume":"190","author":"Levenson","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib141","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nut.2008.10.013","article-title":"Effect of EGb761 supplementation on the content of copper in mouse brain in an animal model of Parkinson's disease","volume":"25","author":"Rojas","year":"2009","journal-title":"Nutrition"},{"key":"10.1016\/j.cbi.2010.04.010_bib142","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00415-006-0301-1","article-title":"Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis","volume":"254","author":"Siciliano","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib143","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.1425","article-title":"Mitochondria and degenerative disorders","volume":"106","author":"Orth","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.cbi.2010.04.010_bib144","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11910-996-0008-9","article-title":"Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene","volume":"6","author":"Andersen","year":"2006","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.cbi.2010.04.010_bib145","doi-asserted-by":"crossref","first-page":"11263","DOI":"10.1073\/pnas.0704307104","article-title":"Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS","volume":"104","author":"Banci","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib146","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cbi.2010.04.010_bib147","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng0596-43","article-title":"Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury","volume":"13","author":"Reaume","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cbi.2010.04.010_bib148","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3940(93)90576-7","article-title":"Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum","volume":"162","author":"Okamoto","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2010.04.010_bib149","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3940(88)90081-X","article-title":"Ubiquitin deposits in anterior horn cells in motor neurone disease","volume":"93","author":"Leigh","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2010.04.010_bib150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00687373","article-title":"Lewy body-like hyaline inclusions in sporadic motor neuron disease are ubiquitinated","volume":"77","author":"Kato","year":"1989","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cbi.2010.04.010_bib151","first-page":"41","article-title":"Sporadic amyotrophic lateral sclerosis with dementia and Cu\/Zn superoxide dismutase-positive Lewy body-like inclusions","volume":"15","author":"Matsumoto","year":"1996","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.cbi.2010.04.010_bib152","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1073\/pnas.0602046103","article-title":"Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria","volume":"103","author":"Deng","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib153","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00775-006-0099-4","article-title":"Superoxide dismutase 1 modulates expression of transferrin receptor","volume":"11","author":"Danzeisen","year":"2006","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib154","doi-asserted-by":"crossref","first-page":"e1677","DOI":"10.1371\/journal.pone.0001677","article-title":"SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization","volume":"3","author":"Banci","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cbi.2010.04.010_bib155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"1366","author":"Beal","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2010.04.010_bib156","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(94)90213-5","article-title":"Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease","volume":"182","author":"Ince","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2010.04.010_bib157","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-510X(95)00037-3","article-title":"Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study","volume":"130","author":"Kasarskis","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib158","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0006-8993(94)90202-X","article-title":"The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis","volume":"650","author":"Leveugle","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib159","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.1252","article-title":"Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord","volume":"50","author":"Olsen","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1523\/JNEUROSCI.5443-08.2009","article-title":"Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"29","author":"Jeong","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib161","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-006-0122-4","article-title":"Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis","volume":"112","author":"Mizuno","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cbi.2010.04.010_bib162","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1440-1789.2007.00873.x","article-title":"Bunina bodies in amyotrophic lateral sclerosis","volume":"28","author":"Okamoto","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.cbi.2010.04.010_bib163","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2004.08.003","article-title":"Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences","volume":"227","author":"Wang","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib164","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev.physiol.64.081501.155838","article-title":"Mechanisms of iron accumulation in hereditary hemochromatosis","volume":"64","author":"Fleming","year":"2002","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cbi.2010.04.010_bib165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0090-3019(02)00723-1","article-title":"Ruptured intracranial dermoid cysts","volume":"57","author":"Stendel","year":"2002","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib166","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0361-9230(01)00510-X","article-title":"Iron and neurodegenerative disorders","volume":"55","author":"Thompson","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.cbi.2010.04.010_bib167","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-510X(96)05334-8","article-title":"Essential trace element alterations in amyotrophic lateral sclerosis","volume":"147","author":"Kapaki","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib168","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/mol.106.028415","article-title":"Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis","volume":"71","author":"Ahtoniemi","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2010.04.010_bib169","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1474-9726.2006.00200.x","article-title":"Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model","volume":"5","author":"Li","year":"2006","journal-title":"Aging Cell"},{"key":"10.1016\/j.cbi.2010.04.010_bib170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tox.2006.09.011","article-title":"Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis","volume":"229","author":"Tokuda","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2010.04.010_bib171","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2008.05.011","article-title":"Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis","volume":"213","author":"Tokuda","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib172","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/awh704","article-title":"Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models","volume":"129","author":"Jonsson","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.cbi.2010.04.010_bib173","doi-asserted-by":"crossref","first-page":"15923","DOI":"10.1074\/jbc.M112087200","article-title":"Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis","volume":"277","author":"Hayward","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib174","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1073\/pnas.0730423100","article-title":"CuZnSOD and amyotrophic lateral sclerosis","volume":"100","author":"Valentine","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cbpa.2006.02.034","article-title":"Pathogenic superoxide dismutase structure, folding, aggregation and turnover","volume":"10","author":"Hart","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.cbi.2010.04.010_bib176","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/S1386-1425(03)00135-5","article-title":"Fluorescence assay for monitoring Zn-deficient superoxide dismutase in vitro","volume":"59","author":"Martyshkin","year":"2003","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.cbi.2010.04.010_bib177","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1126\/science.286.5449.2498","article-title":"Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase","volume":"286","author":"Est\u00e9vez","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cbi.2010.04.010_bib178","doi-asserted-by":"crossref","first-page":"30104","DOI":"10.1074\/jbc.273.46.30104","article-title":"Reactions of hydrogen peroxide with familial amyotrophic lateral sclerosis mutant human copper\u2013zinc superoxide dismutases studied by pulse radiolysis","volume":"273","author":"Goto","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib179","doi-asserted-by":"crossref","first-page":"e5004","DOI":"10.1371\/journal.pone.0005004","article-title":"Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase","volume":"4","author":"Oztug Durer","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cbi.2010.04.010_bib180","doi-asserted-by":"crossref","first-page":"17266","DOI":"10.1074\/jbc.M500482200","article-title":"Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation","volume":"280","author":"Furukawa","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib181","doi-asserted-by":"crossref","first-page":"47998","DOI":"10.1074\/jbc.M406021200","article-title":"The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status","volume":"279","author":"Arnesano","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib182","doi-asserted-by":"crossref","first-page":"28087","DOI":"10.1074\/jbc.M704465200","article-title":"Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1","volume":"282","author":"Niwa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib183","doi-asserted-by":"crossref","first-page":"54558","DOI":"10.1074\/jbc.M409744200","article-title":"Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability","volume":"279","author":"Doucette","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib184","doi-asserted-by":"crossref","first-page":"15893","DOI":"10.1073\/pnas.0403979101","article-title":"Folding of human superoxide dismutase: disulfide reduction prevents dimerization and produces marginally stable monomers","volume":"101","author":"Lindberg","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib185","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.1021\/ja015953r","article-title":"Extensive investigations on oxidized amino acid residues in H(2)O(2)-treated Cu,Zn-SOd protein with LC-ESI-Q-TOF-MS, MS\/MS for the determination of the copper-binding site","volume":"123","author":"Kurahashi","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2010.04.010_bib186","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jmb.2007.07.043","article-title":"Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS","volume":"373","author":"Roberts","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cbi.2010.04.010_bib187","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1073\/pnas.93.12.5709","article-title":"A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide","volume":"93","author":"Yim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib188","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1021\/bi000846f","article-title":"Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper\u2013zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant","volume":"39","author":"Liu","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2010.04.010_bib189","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.freeradbiomed.2007.02.004","article-title":"Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis","volume":"42","author":"Watanabe","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2010.04.010_bib190","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1073\/pnas.94.21.11546","article-title":"Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces","volume":"94","author":"Mukhopadhyay","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib191","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1523\/JNEUROSCI.2000-04.2004","article-title":"Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"24","author":"Kiaei","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib192","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.emboj.7600031","article-title":"A novel role for XIAP in copper homeostasis through regulation of MURR1","volume":"23","author":"Burstein","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2010.04.010_bib193","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.molcel.2006.01.033","article-title":"XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders","volume":"21","author":"Mufti","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cbi.2010.04.010_bib194","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","article-title":"Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria","volume":"43","author":"Pasinelli","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2010.04.010_bib195","doi-asserted-by":"crossref","first-page":"RC215","DOI":"10.1523\/JNEUROSCI.22-06-j0001.2002","article-title":"Mutant Cu\u2013Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS","volume":"22","author":"Higgins","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib196","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.132260399","article-title":"Amyotrophic lateral sclerosis: a proposed mechanism","volume":"99","author":"Okado-Matsumoto","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib197","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bbrc.2005.05.014","article-title":"Beta-lactam antibiotics are multipotent agents to combat neurological diseases","volume":"333","author":"Ji","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2010.04.010_bib198","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1471-4159.2007.04604.x","article-title":"The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"102","author":"Petri","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib199","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1460-9568.1997.tb01511.x","article-title":"The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis","volume":"9","author":"Hottinger","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib200","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1097\/00001756-200008030-00029","article-title":"N-acetyl-l-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis","volume":"11","author":"Andreassen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.cbi.2010.04.010_bib201","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exnr.2001.7633","article-title":"Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice","volume":"168","author":"Andreassen","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(99)00227-X","article-title":"Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice","volume":"265","author":"Nagano","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2010.04.010_bib203","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0014-4886(02)00014-6","article-title":"The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice","volume":"179","author":"Nagano","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib204","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.271.5248.515","article-title":"Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis","volume":"271","author":"Wiedau-Pazos","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cbi.2010.04.010_bib205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1097-4695(200001)42:1<49::AID-NEU5>3.0.CO;2-7","article-title":"Prevention of mutant SOD1 motoneuron degeneration by copper chelators in vitro","volume":"42","author":"Azzouz","year":"2000","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.cbi.2010.04.010_bib206","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0162-0134(98)00012-9","article-title":"Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats","volume":"70","author":"Ogra","year":"1998","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib207","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/WCO.0b013e3282f12074","article-title":"Huntington's disease phenocopy syndromes","volume":"20","author":"Wild","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib208","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1371\/journal.pone.0000334","article-title":"Mechanisms of copper ion mediated Huntington's disease progression","volume":"2","author":"Fox","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cbi.2010.04.010_bib209","doi-asserted-by":"crossref","unstructured":"The Huntington's Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell 72 (1993) 971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.1016\/j.cbi.2010.04.010_bib210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/exnr.1998.6832","article-title":"Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways","volume":"152","author":"Velier","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib211","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/9.19.2789","article-title":"Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles","volume":"9","author":"Hilditch-Maguire","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2010.04.010_bib212","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuroscience.2004.05.054","article-title":"Expanded huntingtin activates the c-Jun terminal kinase\/c-Jun pathway prior to aggregate formation in striatal neurons in culture","volume":"127","author":"Garcia","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbi.2010.04.010_bib213","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/pn.2007.134585","article-title":"The differential diagnosis of chorea","volume":"7","author":"Wild","year":"2007","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib214","first-page":"293","article-title":"Assessment of in vitro and in vivo mitochondrial function in Friedreich's ataxia and Huntington's disease","volume":"277","author":"Schapira","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cbi.2010.04.010_bib215","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib216","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archneur.56.5.569","article-title":"Increased basal ganglia iron levels in Huntington disease","volume":"56","author":"Bartzokis","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib217","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease","volume":"47","author":"de la Monte","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib218","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib219","first-page":"275","article-title":"MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease","volume":"14","author":"Chen","year":"1993","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.cbi.2010.04.010_bib220","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cbi.2010.04.010_bib221","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1471-4159.2003.01980.x","article-title":"Depletion of wild-type huntingtin in mouse models of neurologic diseases","volume":"87","author":"Zhang","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib222","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(00)02082-5","article-title":"Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease","volume":"862","author":"P\u00e9rez-Severiano","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib223","doi-asserted-by":"crossref","first-page":"1188S","DOI":"10.1093\/ajcn\/54.6.1188s","article-title":"Ascorbic acid and iron metabolism: alterations in lysosomal function","volume":"54","author":"Hoffman","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.cbi.2010.04.010_bib224","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.freeradbiomed.2004.10.025","article-title":"Oxidation-induced ferritin turnover in microglial cells: role of proteasome","volume":"38","author":"Mehlhase","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2010.04.010_bib225","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1073\/pnas.84.23.8478","article-title":"Iron regulates ferritin mRNA translation through a segment of its 5\u2032 untranslated region","volume":"84","author":"Aziz","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib226","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0169-328X(99)00011-X","article-title":"Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain","volume":"65","author":"Hansen","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib227","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2010.04.010_bib228","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2010.04.010_bib229","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.10295","article-title":"Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6\/2 transgenic mice","volume":"449","author":"Meade","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib230","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib231","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2003.03.001","article-title":"Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease","volume":"25","author":"Bartzokis","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2010.04.010_bib232","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/hmg\/ddm138","article-title":"Huntingtin-deficient zebrafish exhibit defects in iron utilization and development","volume":"16","author":"Lumsden","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2010.04.010_bib233","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib234","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib235","doi-asserted-by":"crossref","first-page":"18707","DOI":"10.1074\/jbc.M603354200","article-title":"Of two cytosolic aconitases expressed in Drosophila, only one functions as an iron-regulatory protein","volume":"281","author":"Lind","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib236","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1432-1033.1994.tb18696.x","article-title":"Control of cellular iron homeostasis by iron-responsive elements in vivo","volume":"220","author":"Ward","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cbi.2010.04.010_bib237","doi-asserted-by":"crossref","first-page":"29405","DOI":"10.1016\/S0021-9258(18)43893-8","article-title":"Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not","volume":"269","author":"Hausladen","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2010.04.010_bib238","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2010.04.010_bib239","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0005-2728(98)00164-9","article-title":"Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia","volume":"1410","author":"Schapira","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2010.04.010_bib240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0891-5849(94)90239-9","article-title":"The role of O2\u2022\u2212 in the production of HO.: in vitro and in vivo","volume":"16","author":"Liochev","year":"1994","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2010.04.010_bib241","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1749-6632.1999.tb07827.x","article-title":"Bioenergetics in Huntington's disease","volume":"893","author":"Gr\u00fcnewald","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2010.04.010_bib242","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.04.010_bib243","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.04.010_bib244","series-title":"Metals and Oxidative Damage in Neurological Disorders","first-page":"131","article-title":"Ferritin: intracellular regulator of metal availability","author":"Joshi","year":"1997"},{"key":"10.1016\/j.cbi.2010.04.010_bib245","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1111\/j.1742-4658.2006.05537.x","article-title":"Huntingtin inclusion bodies are iron-dependent centers of oxidative events","volume":"273","author":"Firdaus","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2010.04.010_bib246","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","article-title":"Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model","volume":"102","author":"Nguyen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2010.04.010_bib247","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuro.2007.02.004","article-title":"Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy","volume":"28","author":"Ferrada","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2010.04.010_bib248","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2010.04.010_bib249","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1096\/fj.09-135749","article-title":"Divalent metal transporter 1 is involved in amyloid precursor protein processing and A\u03b2 generation","volume":"23","author":"Zheng","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2010.04.010_bib250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0006-8993(92)91193-I","article-title":"Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease","volume":"585","author":"Kalaria","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib251","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neuropharm.2009.09.002","article-title":"Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake","volume":"58","author":"Xu","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2010.04.010_bib252","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/jnr.21430","article-title":"Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx","volume":"35","author":"Song","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cbi.2010.04.010_bib253","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M312497200","article-title":"\u03b1-Synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide","volume":"279","author":"Kalivendi","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710002711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710002711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:21:42Z","timestamp":1757856102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279710002711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":253,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0009279710002711"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2010.04.010","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The transition metals copper and iron in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2010.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}